Form 8-K INCYTE CORP For: Jun 22

Go back to Form 8-K INCYTE CORP For: Jun 22

Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules

June 22, 2026 7:53 AM EDT

Incyte Corporation (NASDAQ: INCY) has reached a settlement with the Centers for Medicare & Medicaid Services (CMS) over a dispute regarding Medicaid rebate rules applied to its drug Opzelura (ruxolitinib) cream, according to a company statement.

Under the agreement, CMS will not classify... More